Pluri (PLUR) Gross Margin (2011 - 2025)
Pluri (PLUR) reported Gross Margin of 43.43% for Q4 2025, down 1657.0% year-over-year from 2.79% in Q4 2024, and up 19.35% quarter-over-quarter from 36.39% in Q3 2025.
Pluri (PLUR) Gross Margin (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 11 years of Gross Margin data on file, last reported at 43.43% in Q4 2025.
- Gross Margin for Q4 2025 came in at 43.43%, down 1657.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 40.63% (down 2928.0% YoY), and the FY2025 annual result was 48.95%, down 4982.0% from the prior year.
- Gross Margin improved to 43.43% in Q4 2025 per PLUR's latest filing, from 36.39% in the prior quarter.
- Over five years, Gross Margin peaked at 100.0% in Q3 2023 and troughed at 31.85% in Q1 2025.
- A 3-year average of 68.09% and a median of 60.67% in 2024 frame the typical range for Gross Margin.
- On a YoY basis, Gross Margin climbed as much as 1657 bps in 2025 and fell as far as 6815 bps in 2025.
- A 3-year view of Gross Margin shows it stood at 100.0% in 2023, then plunged by 40 bps to 60.0% in 2024, then declined by 28 bps to 43.43% in 2025.
- Business Quant data shows PLUR's Gross Margin at 43.43% in Q4 2025, 36.39% in Q3 2025, and 52.01% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 43.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.43% |
| Sep 30, 2025 | 36.39% |
| Jun 30, 2025 | 52.01% |
| Mar 31, 2025 | 31.85% |
| Dec 31, 2024 | 60.00% |
| Sep 30, 2024 | 61.35% |
| Jun 30, 2024 | 95.83% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | 100.00% |
| Dec 31, 2019 | 95.65% |
| Dec 31, 2018 | 96.00% |
| Sep 30, 2018 | 100.00% |
| Dec 31, 2017 | 96.00% |
| Dec 31, 2015 | 96.48% |
| Sep 30, 2015 | 96.84% |
| Dec 31, 2014 | 95.79% |
| Sep 30, 2014 | 96.84% |
| Jun 30, 2014 | 97.87% |
| Mar 31, 2014 | 96.84% |